Trial Profile
A Phase II, Single-Centre, Randomised, Controlled, Open-Label Clinical Trial to Compare the Efficacy and Safety of Three Therapeutic Interventions on the Treatment of Hypothalamic Obesity due to Childhood Cancer with Cranial Insults.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2011
Price :
$35
*
At a glance
- Drugs Lanreotide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 01 Jun 2011 New trial record